Product Information
DOXAZOSIN MESYLATE 8 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1070 per EA under NDC 59762248007. Its NADAC has been published 235 times since Dec 29, 2021.
The High Outlier badge above means this manufacturer's average price in the doxazosin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
8 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762248007
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DOXAZOSIN MESYLATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA019668On Market Since
10/19/2021
Pharmacological Classes
Price Statistics
The NADAC for DOXAZOSIN MESYLATE 8 MG TAB has been published 235 times since Dec 29, 2021, and over the history we have for it it has declined 21.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1070 per EA |
|---|---|
| All-time high | $0.1500 (Feb 14, 2024) |
| All-time low | $0.0731 (Nov 20, 2024) |
| 52-week high | $0.1097 |
| 52-week low | $0.0965 |
| Median price | $0.1080 |
| Average price | $0.1079 |
| Largest weekly change | +33.1% (Feb 22, 2023) |
| Weeks tracked | 235 |
| Tracking since | Dec 29, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the doxazosin market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of DOXAZOSIN MESYLATE 8 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DOXAZOSIN MESYLATE 8 MG TAB, manufactured by Mylan Pharmaceuticals Inc., is $0.1070 per EA (NDC 59762248007), effective Jun 24, 2026.
How has the price of DOXAZOSIN MESYLATE 8 MG TAB changed over time?
Over the history we have for it, the NADAC for DOXAZOSIN MESYLATE 8 MG TAB has declined 21.2%. It has been tracked across 235 weekly CMS publications since Dec 29, 2021.
What are the highest and lowest recorded NADAC prices for DOXAZOSIN MESYLATE 8 MG TAB?
Since Dec 29, 2021, the NADAC for DOXAZOSIN MESYLATE 8 MG TAB has ranged from a low of $0.0731 (Nov 20, 2024) to a high of $0.1500 (Feb 14, 2024), with a median of $0.1080 per EA.
Are there cheaper alternatives to DOXAZOSIN MESYLATE 8 MG TAB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DOXAZOSIN MESYLATE 8 MG TAB, so no direct lower-cost alternative is listed.
Who manufactures DOXAZOSIN MESYLATE 8 MG TAB?
DOXAZOSIN MESYLATE 8 MG TAB (NDC 59762248007) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification